机构:[a]Heart Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510006, PR China广东省中医院大学城医院心血管一科心血管科大学城医院二沙岛医院心血管科(重症医学科)心血管科二沙岛医院[b]Department of Critical-Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510006, PR China大德路总院重症医学科大德路总院重症医学科广东省中医院
Objective: The study aimed to investigate whether a Shengmai San-derived herbal, Fumai granule (FM), which had a preventive effect on atrial fibrillation (AF) in myocardial infarction (MI)-induced heart failure (HF) rat and to determine the underlying mechanisms. Design and methods: MI was induced by a ligation of the left anterior descending coronary artery. One week after MI surgery, FM was gavaged for 4 weeks. AF inducibility was detected by transesophageal programmed electrical stimulation technology. Multielectrode array measurements, echocardiogram, histology, and western blotting were performed. Results: The FM-treated group had lower rates of AF inducibility and shorter AF duration compared to the MI group. FM improved the conduction velocity and homogeneity, decreased left atrial positive fibrosis areas and expression of type I and III collagen, inhibited cardiac fibroblast to myofibroblast differential, and increased the expression of connexin 43 and connexin 40 in the left atrium. Conclusions: These results suggest that FM reduced the AF inducibility after MI by improving the left atrial conduction function via inhibiting left atrial fibrosis and increasing the expression of connexin, indicating its benefit in preventing the MI-induced vulnerable substrate for AF.
基金:
This work was supported by grant from Natural Science Foundation
of China (#81503394 to Jin Ma), Guangdong science and Technology Foundation (#2014A020221026 to Jin Ma), Natural Science
Foundation of Guangdong Provincial (#2015A030313354,
#2016A030313634 to Shiyu Ma, #2017A030313888 to Jin Ma),
Guangzhou science and Technology Foundation (#201607010364 to
Shiyu Ma).
基金编号:#81503394 to Jin Ma
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|3 区医学
小类|3 区药学4 区医学:研究与实验
最新[2025]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区药学
JCR分区:
出版当年[2016]版:
Q2MEDICINE, RESEARCH & EXPERIMENTALQ2PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[a]Heart Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510006, PR China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Jin Ma,Shiyu Ma,Chunxia Yin,et al.Shengmai San-derived herbal prevents the development of a vulnerable substrate for atrial fibrillation in a rat model of ischemic heart failure[J].BIOMEDICINE & PHARMACOTHERAPY.2018,100:156-167.doi:10.1016/j.biopha.2018.02.013.
APA:
Jin Ma,Shiyu Ma,Chunxia Yin&Huanlin Wu.(2018).Shengmai San-derived herbal prevents the development of a vulnerable substrate for atrial fibrillation in a rat model of ischemic heart failure.BIOMEDICINE & PHARMACOTHERAPY,100,
MLA:
Jin Ma,et al."Shengmai San-derived herbal prevents the development of a vulnerable substrate for atrial fibrillation in a rat model of ischemic heart failure".BIOMEDICINE & PHARMACOTHERAPY 100.(2018):156-167